MediPines

MediPines is a pioneer and market leader in non-invasive pulmonary gas exchange technology. The company's mission is to advance respiratory medicine by providing physiology-based cardiopulmonary devices, improving clinical outcomes, and achieving superior patient results. The MediPines AGM100 is an industry award-winning, FDA-approved advanced pulmonary gas exchange technology that specifically provides an alternative to oxygen deficiency as alveolar-arterial oxygen difference (AaDO2), along with blood oxygen levels (gPaO2), alveolar carbon dioxide levels (PETCO2), and other sensitive pulmonary gas exchange measurements relevant to the assessment of respiratory (and cardiac) patients. Healthcare providers and clinicians use the AGM100 to enhance diagnostic accuracy, improve treatment decisions, and expedite medical decision-making.